Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultiva with Xylocaine for feticide procedures
2015-002856-28Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Montpellier
- Start
- Aug 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in medical abortion comparing Ultiva + Xylocaine with Sufentanil + Xylocaine (2 arms). Primary endpoint: Time to asystole. Started Aug 2015; status: completed.
02
Drugs
remifentanillidocaine
03
Conditions
medical abortion
Beyond the preview
Go deeper on 2015-002856-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002856-28.